Last week, NPR’s "All Things Considered" covered an unusual topic: Scientific conference posters. For the first time in decades, scientists are rethinking the traditional design of the posters they ...

- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on the Use of Splicing Correction as a Prognostic Biomarker of Functional Outcomes in DM1 - Poster sessions are from 6:00 p ...

Del-zota produced statistically significant increases in exon skipping and dystrophin levels in EXPLORE44, a Phase 1/2 study in patients with DMD44 (oral presentation) Aravindhan Veerapandiyan, MD, ...

Ahead of her presentation at JP Morgan, Pharmaceutical Technology spoke with Dr. Jennifer Levin Carter, MD, founder and CEO ...

Scientific paper accepted for presentation at American Roentgen Ray Society Annual Meeting, Chicago, IL, May 1-6, 2011. McArthur TA, Lockhart ME, Planz V, Fineberg NS, and Berland LL. CT of the Common ...

The process through which research presented at scientific meetings is ultimately published in peer‐reviewed journals has become an important indicator of both scientific rigour and the potential ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...

AUSTIN, Texas, July 09, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq:SAVA), a biotechnology company focused on Alzheimer’s disease, today announced that its lead neuroscientist, Lindsay H.

Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.